USPTO serial 79162860
BDM
Reviewed by CopyMark Law Group
Reg. 4920092Status 404
- Filing date
- Status date
- Registration date
- Mar 22, 2016
- Examiner
- VAGHANI, MAYUR C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BDM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Dickson + Dickson Healthcare Limited
AU
Other trademarks owned by Dickson + Dickson Healthcare Limited
Dickson + Dickson Healthcare Limited
AU
Other trademarks owned by Dickson + Dickson Healthcare Limited
Dickson + Dickson Healthcare Limited
AU
Other trademarks owned by Dickson + Dickson Healthcare Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael A. Bondi
Michael A. Bondi Moss & Barnett150 South Fifth Street, Suite 1200Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and medical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, hepatological, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; sanitary preparations for medical use, sterilising preparations; medical and surgical plasters; bandages for dressings, bandages for skin wounds, surgical bandages, antiseptic liquid bandages; medical and surgical dressings, wound dressings; all-purpose disinfectants, disinfectants for medical instruments; disinfectants for sanitary purposes | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus and instruments for the treatment of treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, hepatological, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; surgical apparatus and instruments for the treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; surgical apparatus and instruments for the treatment of inflammatory disorders; surgical apparatus and instruments for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders, for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines, for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, hepatological, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; protective clothing for medical use being caps, gowns, footwear, masks, face shields, overboots, sleeves and gloves; protective bedding the nature of surgical sterile sheets; surgical sterile bed, trolley, and tray covers, drapes and sheeting for hospital and surgical use; suture materials; medical syringes; medical needles; containers for disposal of syringes, needles, contaminated substances and medical waste | SECTION 71 - CANCELLED | — |
| 016 | Disposable products of paper and cellulose for personal use being paper and cellulose wipes, bibs, napkins and unfitted seat covers for chairs, wheelchairs, commodes and toilets | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Dickson + Dickson Healthcare Limited
- Other trademarks owned by Dickson + Dickson Healthcare Limited
- Other trademarks owned by Dickson + Dickson Healthcare Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Similar marks named BDM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 12, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Apr 12, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 31, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 11, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 11, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jun 7, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Oct 7, 2022 | C71T | CANCELLED SECTION 71 | — |
| Mar 22, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 22, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 1, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 1, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 22, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 22, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 5, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 4, 2016 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 16, 2015 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 16, 2015 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Nov 25, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 25, 2015 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 25, 2015 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2015 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 25, 2015 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 24, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 6, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 6, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 29, 2015 | ALIE | ASSIGNED TO LIE | — |
| Oct 9, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 8, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 25, 2015 | CRSN | CORRECTION SENT TO IB | — |
| Apr 25, 2015 | CRCR | CORRECTION CREATED FOR IB | — |
| Apr 24, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 10, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 9, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 9, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 6, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2015 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Apr 2, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |